J Bacteriol, May 1998, p. 2359-2366, Vol. 180, No. 9
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Department of Medicine, University of
California, San Francisco, San Francisco, California
94143-0654,1 and
Department of
Bacteriology, University of Wisconsin
Madison, Madison, Wisconsin
537062
Received 29 January 1998/Accepted 6 March 1998
| |
ABSTRACT |
|---|
|
|
|---|
We have characterized the Chlamydia trachomatis
ribosomal promoter, rRNA P1, by measuring the effect of substitutions
and deletions on in vitro transcription with partially purified
C. trachomatis RNA polymerase. Our analyses indicate that
rRNA P1 contains potential
10 and
35 elements, analogous to
Escherichia coli promoters recognized by
E-
70. We identified a novel AT-rich region immediately
downstream of the
35 region. The effect of this region was specific
for C. trachomatis RNA polymerase and strongly attenuated
by single G or C substitutions. Upstream of the
35 region was an
AT-rich sequence that enhanced transcription by C. trachomatis and E. coli RNA polymerases. We propose
that this region functions as an UP element.
| |
INTRODUCTION |
|---|
|
|
|---|
Chlamydia trachomatis is
a gram-negative obligate intracellular pathogen with a biphasic
developmental life cycle (reviewed in references 16
and 20). We have been characterizing the transcriptional machinery and defining the structure of chlamydial promoters. C. trachomatis RNA polymerase (RNAP) resembles
other eubacterial RNAPs in being a multisubunit enzyme containing
,
,
', and
subunits (3, 4, 11, 12). Three
subunits have been identified in Chlamydia to date.
A is a homolog of
70, and two alternative
subunits show sequence homology to Escherichia coli
54 and Bacillus subtilis
28,
respectively (21).
A shows striking amino
acid sequence conservation with
70 in subregions 2.4 and
4.2 (3, 12), which recognize the
10 and
35 promoter
elements, respectively. Within these regions, specific amino acid
residues that have been shown to be involved in promoter recognition
are completely conserved (14).
It is not clear if this striking conservation in the
promoter
recognition domains is accompanied by conservation of promoter structure between C. trachomatis and E. coli.
Consensus
70
10 promoter sequences can be recognized
upstream of the transcription initiation sites of many C. trachomatis genes (7). Some, but not all, of these
genes also have
35 promoter sequences spaced an optimal 16 to 18 bp
upstream of the
10 promoter sequences (6, 8, 13, 23).
However, other chlamydial genes are not preceded by recognizable
70 promoter sequences.
In vitro transcription studies have begun to define the structures of
promoters in C. trachomatis. Matthews and Sriprakash found
that in vitro promoter activity was reduced or eliminated by multiple
mutations in the predicted
10 and
35 regions of the plasmid
countertranscript (PCT) promoter, although single substitutions had no
measurable effect (15). Douglas and Hatch showed that
sequences in the
35 region and adjacent AT-rich regions were
important for major outer membrane protein (MOMP) P2 promoter activity
in vitro (2). The predicted
10 hexamer of MOMP P2, TATCGC, differed from the E. coli
10 hexamer by
the presence of C and G residues in the last three positions, but only
the first two bases of this hexamer were important for promoter
activity.
We have been characterizing C. trachomatis rRNA P1 by in
vitro transcription with heparin-agarose-purified C. trachomatis RNAP. rRNA is highly transcribed, and rRNA P1 is
likely to be a strong promoter. In E. coli, the rRNA
promoters are among the strongest promoters and are very close in
sequence to the consensus
70 promoter. E. coli rRNA promoters also contain a third promoter element, the UP
element, that can enhance transcription as much as 30-fold
(17). Unlike
10 and
35 promoter elements, which are
recognized by
70, the UP element is recognized by the
carboxy-terminal domain of the
subunit of RNAP (
-CTD). While UP
elements have not been previously identified in C. trachomatis, the amino acids of
that recognize the UP element
are completely conserved between E. coli and C. trachomatis (10, 11).
In our previous study, we used 5' deletions and 5-bp substitutions of
rRNA P1 to demonstrate that sequences in the approximate
10 and
35
regions were required for promoter activity with C. trachomatis or E. coli
70 RNAP
(22). This analysis also defined a region within
26 to
22 that was required for transcription by partially purified C. trachomatis RNAP but not by E. coli RNAP.
To further define the specific bases required for transcription by
C. trachomatis RNAP, we performed saturation mutagenesis of
rRNA P1 by constructing single base substitutions from
41 to
1. The
effects of these substitutions on transcription by C. trachomatis and E. coli RNAPs were compared. Our
results defined four regions that contributed to in vitro transcription
by partially purified C. trachomatis RNAP.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Reagents. Products were obtained from the following sources and were used according to the manufacturers' specifications. Restriction enzymes, bacterial alkaline phosphatase, and T4 DNA ligase were from Gibco BRL (Gaithersburg, Md.); T4 polynucleotide kinase was from Boehringer Mannheim Biochemicals (Indianapolis, Ind.); RNasin and RQ1 DNase were from Promega Biotech (Madison, Wis.); SP6 RNA polymerase was from Ambion (Austin, Tex.); Sequenase DNA polymerase was from United States Biochemical Corp. (Cleveland, Ohio); Thermus aquaticus DNA polymerase was from Cetus Corp. (Emeryville, Calif.); 32P-containing nucleoside triphosphates were from Amersham Corp. (Arlington Heights, Ill.); SeaPlaque and SeaKem agarose were from FMC Bioproducts (Rockland, Maine); ampicillin and gentamicin sulfate were from Sigma Chemical Co. (St. Louis, Mo.); vancomycin hydrochloride was from Abbott Laboratories (North Chicago, Ill.), and dimethyl sulfoxide was from Fisher Scientific (Pittsburgh, Pa.).
DNA manipulation. Standard recombinant DNA methods were used for nucleic acid preparation and analysis (18). DNA was amplified by PCR as described previously (22). DNA sequencing was performed with the dideoxy-chain termination method (19) using a Sequenase kit (United States Biochemical Corp.) on double-stranded plasmid DNA.
Synthetic oligonucleotides.
The following single-stranded
oligonucleotide primers were synthesized by Gibco BRL: M13 forward
40, 5' GTTTT CCCAG TCACG AC; M13 reverse
40, 5' GTTGT GTGGA ATTGT
G; pGLS3', 5' ATAGG AGGAA TAATG; rRNA-3, 5' CAGGG TACCA GGCCT CCGCG
TTCAA GA; rRNA-4, 5' CACGA ATTCC GCGTT CAAGA AAGG; Tx1, 5' AAAGT AACAT
CTTAT ATCAA CCTCT; Tx25, 5' TATTA TATAG TGTCA CCTAA AT; Tx27, 5' GGGAA
GAGGG GGTGA GAG; and Tx33, 5' CCGAA CGACC GAGCG CAGCG.
Plasmid containing the rRNA P1 and SP6 control promoters.
pMT589 (Fig. 1) was derived from pMT504
(22) by deletion of the lacZ and T7 promoters on
a 124-bp PvuII-ApaI fragment and construction of
a new SP6 control transcription template. The SP6 promoter was
amplified by PCR, using pGEM-7Zf(+) as the template with M13 reverse
40 and Tx25 primers, and cloned upstream of the control G-less
cassette. The G residue at +1 was replaced with a T residue to allow
for transcription in the absence of GTP. Transcription with SP6 RNAP
produced a 130-nucleotide control transcript.
|
302 to +5), containing the wild-type sequence or a mutation, was
used as the test promoter. The G residue at +1 was replaced with an A
residue to allow for transcription in the absence of GTP. This
substitution did not change the transcription initiation site.
Transcription with C. trachomatis or E. coli RNAP
produced a 158-nucleotide test transcript.
Supercoiled DNA plasmids for use in the in vitro transcription assays
were prepared by using a Qiagen Plasmid Midi Kit (Qiagen Inc.,
Chatsworth, Calif.) according to the manufacturer's directions. The
DNA sequences of the promoter templates were determined to ascertain
that there were no inadvertent mutations from the PCR and cloning
steps.
Construction of rRNA P1 templates containing mutations.
A
300-bp region of rRNA P1 (
302 to +5) was generated by PCR or by the
megaprimer method (see below). PCR was used if the desired mutation was
located close to the transcription start site so that it could be
introduced on a PCR primer. The promoter region was amplified by using
pMT513 (22) as the template, rRNA-4 as the 5' primer, and a
3' primer containing the mutation. The 300-bp PCR product was
phosphorylated, digested with EcoRI, and ligated to plasmid
pMT589 previously digested with EcoRI and EcoRV.
Megaprimer method for generating promoter templates with mutations. A modification of the megaprimer method (22) was used to introduce mutations that could not be located on a primer for one-step PCR amplification. The megaprimer was generated by PCR with pMT513 as the template, pGLS3' as the 3' primer, and a mutation-containing 5' primer. The 200-bp megaprimer was electrophoresed and recovered from an agarose gel (22). The megaprimer was extended with Sequenase DNA polymerase, using 100 ng of heat-denatured, linearized plasmid pMT175 (22) as the template in a 10-µl reaction volume. Two microliters of the extended megaprimer mix was used as the template in a second PCR with 100 pmol of primers Tx33 and Tx27 and 10% (vol/vol) dimethyl sulfoxide. The 600-bp PCR product was recovered from an agarose gel, digested with EcoRI and DraI, and ligated to plasmid pMT589 previously digested with EcoRI and EcoRV.
In vitro transcription.
The method used is as described in
reference 22 with slight modifications. The
following reaction mixture was assembled and preincubated on ice for 30 min: 50 mM potassium acetate, 8.1 mM magnesium acetate, 50 mM Tris
acetate (pH 8.0), 27 mM ammonium acetate, 2 mM dithiothreitol, 400 µM
ATP, 400 µM UTP, 1.2 µM CTP, 0.21 µM [
-32P]CTP
(3,000 Ci/mmol), 100 µM 3'-O-methylguanosine
5'-triphosphate, Na salt (Pharmacia Biotech, Piscataway, N.J.), 18 U of
RNasin, 10% glycerol, and 5 U of SP6 RNA polymerase. The DNA template (final concentration, 25 nM) and 0.25 µl of heparin-agarose-purified C. trachomatis RNAP (22) were added, and the
reaction mixture was incubated at 37°C for 5 min. Heparin was added
to a final concentration of 150 µg/ml, and the incubation was
continued at 37°C for a further 10 min. The final reaction volume was
10 µl. The reaction was stopped by the addition of 10 µl of stop
solution (95% formamide, 20 mM EDTA, 0.05% bromophenol blue, 0.05%
xylene cyanol); 7 µl of the sample was electrophoresed on an 8 M
urea-6% polyacrylamide gel. Transcripts were visualized by
autoradiography and quantified with a Molecular Dynamics (Sunnyvale,
Calif.) PhosphorImager. The size of the transcript was determined by
coelectrophoresis with an M13 sequencing ladder. A single preparation
of C. trachomatis RNAP was used for the transcription
reactions in this study.
70 RNAP (Epicentre Technologies, Madison, Wis.) was used
instead of C. trachomatis RNAP. In these experiments, 3 U of
SP6 RNA polymerase was used to transcribe the control SP6 promoter.
E. coli RNAP containing wild-type
or a truncation of the
-CTD were reconstituted in vitro from purified subunits as described
previously (10, 17).
Calculation of promoter activity. For each promoter template, transcription with C. trachomatis RNAP (or E. coli RNAP) was normalized to a control SP6 RNAP transcript, which corrected for DNA concentration and sample handling. The promoter activity obtained with wild-type rRNA P1 was defined as 100%, and the promoter activity of each mutant promoter was normalized to this value. For each mutant promoter, three measurements of promoter activity were obtained and a mean and standard deviation were calculated.
Primer extension analysis of in vitro transcription
products.
Unlabeled in vitro transcripts were synthesized as
described above, with the following changes: each 10-µl reaction
mixture contained 2 µl of C. trachomatis RNAP (or 0.05 U
of E. coli RNAP), 400 µM CTP, and no
[
-32P]CTP. Prior to primer extension analysis, RNA
samples were treated with RQ1 DNase to remove the DNA template. Primer
extension analysis was carried out as previously described
(5) with 32P-end-labeled primer Tx27, which is
complementary to the extreme 3'-end of the test G-less cassette
template. Primer extension products were electrophoresed next to a
Tx27-primed DNA sequence of pMT513 (22).
| |
RESULTS |
|---|
|
|
|---|
We have renumbered the positions of rRNA P1 since our previous
study (22). We have shifted +1 downstream one position, as repeat primer extension studies have localized the in vitro
transcription initiation site to this position (data not shown). The
base at the new +1 position is a G residue. The three adjacent in vivo start sites (5) are now at positions
1, +1, and +2. The
inefficiency of the C. trachomatis transcription system
required that we employ a G-less transcript sequence and use
transcription reactions in which no GTP was added in order to increase
sensitivity and permit quantitation of in vitro transcription
(22). To allow transcription in the absence of GTP, we have
made a substitution of G to A at +1. We cannot rule out the possibility
that this substitution altered the properties of the promoter.
Nevertheless, since E. coli RNAP does not have a preference
for G over A at +1 so long as the initiating nucleoside triphosphate is
provided at a high concentration (reference 9 and
unpublished results), we have made the assumption that C. trachomatis RNAP recognizes rRNA P1 promoters similarly with A or
G at this position.
We tested the effect on in vitro transcription of single base
substitutions at positions
41 to
1 of rRNA P1 (Table
1 and Fig.
2). All three substitutions were tested
for 37 of 41 positions, and two substitutions were tested for each of
the remaining positions. Mutations with effects on transcription
clustered in several regions that were specific for C. trachomatis and E. coli RNAPs.
|
|
Substitutions in the
10 region affected promoter activity.
Substitutions in the
10 region had large effects on transcription by
C. trachomatis RNAP and identified positions that were important for promoter activity. Some substitutions at
11,
10,
9,
8,
7,
5, and
4 had negative effects on promoter activity, while
other substitutions at
10 and
6 had positive effects (Table 1 and
Fig. 2). The greatest effects were seen at
8, where an A-to-G
substitution caused a ninefold decrease in promoter activity, and at
9, where a T-to-A substitution decreased promoter activity fivefold.
The positive effects of a G substitution at
10 and a T substitution
at
6 suggested that these substitutions made the resultant promoter
closer to the optimal promoter sequence. If we took the individual
base(s) that produced the greatest promoter activity at each position,
the sequence was A, G, or T at
11, G or T at
10, T at
9, A at
8, A or T at
7, A or T at
6, A or C at
5, and T at
4. This
optimal sequence contains two potential matches to the
70
10 promoter element, TATAAT, from
11
to
6 and from
9 to
4.
70
10 promoter sequences and
validated this method for identifying the locations of sequences
important for promoter activity. Substitution at
14,
13,
11,
10,
9,
8,
7,
5, and
4 had negative effects, while a G-to-T
substitution at
6 had a positive effect (Table 1 and Fig. 2). The
greatest effect was seen at
8, where an A to C or G substitution
caused an 18-fold decrease in promoter activity. The optimal E. coli
10 sequence was T at
14, G at
13, T at
11, A or G at
10, T at
9, A at
8, A or T at
7, T at
6, A or C at
5, and T
at
4. Two overlapping
70
10 promoter elements are
recognizable within this optimal sequence: a
10 hexamer that also
contains an extended
10 motif, TGnTATAAT from
14 to
6,
and another potential
10 hexamer extending from
9 to
4.
Single base substitutions in the extended
10 promoter motif at
14
and
13 did not affect C. trachomatis RNAP promoter
activity in the context of rRNA P1 (Table 1 and Fig. 2). To confirm
this finding, a 2-bp substitution at these positions (T-14C, G-13T) was
tested. This substitution did not affect C. trachomatis RNAP promoter activity (data not shown).
Substitutions in the
35 region had smaller effects on C. trachomatis RNAP than substitutions in the
10 region.
We
have previously shown that a 5-bp substitution from
31 to
27
decreased transcription by C. trachomatis RNAP
(22). Single substitutions at
32 and
31 had negative
effects, while substitutions
33,
29, and
28 had positive effects
(Table 1 and Fig. 2). Substitutions at
30 had a slight positive
effect. The largest effect was a T-to-C or G substitution at
32 which
decreased promoter activity twofold. The optimal sequence was T at
33, T at
32, A, G or T at
31, G at
29, and A at
28, which
resembles the
70
35 promoter element, TTGACA.
The optimal
35 sequence for E. coli RNAP was T at
33, T at
32, A, G or T at
31, G at
30, A at
29, A at
28,
and A at
27 (Table 1 and Fig. 2). Two overlapping potential
35
elements that resemble the E. coli consensus
35 hexamer
are recognizable, from
33 to
28 and
32 to
27.
Substitutions between the
10 and
35 regions defined an AT-rich
region that affected transcription by C. trachomatis RNAP
but not by E. coli RNAP.
Our previous analysis
suggested that sequences in the spacer region between
10 and
35
regions were important for transcription by C. trachomatis
RNAP but not by E. coli RNAP (22). At positions
26 to
22, changing the wild-type sequence from AAAAA to TTTTT caused a 2-fold decrease in promoter activity, and altering it to CCCCC
resulted in a 12-fold decrease in promoter activity (data not shown).
Within this region, substitution of a single wild-type A residue with a
C or G at
25,
24, and
23 or a C at
22 caused a negative effect
on transcription (Table 1 and Fig. 2 and
3). Substitution of a C at
26 had a
smaller negative effect. Substitution of a T residue at
26,
25, and
23 had a slight stimulatory effect. The greatest effect was seen at
24, where an A-to-C substitution caused a 4.5-fold decrease in
promoter activity. In contrast, transcription by E. coli
RNAP was slightly decreased by C or G substitutions at
23, while
other substitutions in this region had no effect or a slight positive
effect (Table 1 and Fig. 2 and 3). These results defined a region
extending from
25 to
22 and possibly including
26, whose sequence
was important for transcription by C. trachomatis RNAP. We
have called this region the spacer A/T region because of its location
in the spacer region between the
10 and
35 promoter elements and
the sequence preference for A and T residues.
|
Substitutions upstream of the
35 region affected
transcription.
We have previously shown that 5-bp substitutions
from
41 to
37 and
36 to
32 decreased transcription by C. trachomatis and E. coli RNAPs (22). Some
single base substitutions in this region upstream of the putative
35
hexamer affected transcription by C. trachomatis RNAP,
although not as much as they affected transcription by E. coli RNAP (Table 1 and Fig. 2). Most of these deleterious
substitutions were from an A to a C or G. As we will mention below, the
native AT-rich sequence in this location functioned as an UP element
with E. coli RNAP. Thus, it is likely that the substitutions
decreased promoter activity by affecting contacts between the UP
element and RNAP.
Effect of altered spacing between the
10, spacer A/T, and
35
regions.
We tested the effect on promoter activity of insertions
or deletions downstream (at
17) or upstream (at
27) of the spacer A/T region to determine if the spacing between the
10, spacer A/T,
and
35 regions was important (Fig. 4).
A 1-bp insertion or deletion at either location had minimal effects on
transcription by C. trachomatis RNAP (lines B, C, F, and G).
A 2-bp insertion at
27 (line E) but not
17 (line D) had a negative
effect on C. trachomatis and E. coli RNAPs. The
only mutation which specifically decreased transcription by C. trachomatis RNAP but not E. coli RNAP was a 2-bp
deletion at
17 (line H).
|
17
together with a compensatory insertion at
27. These mutations had the
net effect of moving the spacer A/T region without altering the
location of the sequences in the
10 and
35 regions. Shifting the
spacer A/T region 1 and 2 bp downstream decreased the promoter activity
of C. trachomatis RNAP to 41 and 25% of wild-type activity, respectively, but did not affect E. coli RNAP transcription
(lines J and K). These results suggested that in this promoter context, the spacer A/T region could not be moved downstream without adversely affecting transcription and provided additional evidence that the
spacer A/T region affected only transcription by C. trachomatis RNAP.
Substitutions that allowed transcription initiation from a new
site.
Three single base changes each produced an additional
C. trachomatis RNAP transcript that was faster-migrating and
less abundant (Fig. 5A). The 5' end of
each extra transcript was mapped by primer extension to a site 18 downstream of the native rRNA P1 transcription start site (data not
shown). These results demonstrated that the extra transcript was the
result of transcription initiation at a new site, rather than premature
termination. Each of the substitutions appeared to make new promoters
by creating sequences that could function as
35 hexamers (T-11C) or
spacer A/T regions (G-6A and G-6T) in combination with a potential
10
hexamer (TTTAAA) from the G-less cassette (Fig. 5B).
E. coli RNAP only produced an extra transcript with the
substitution that created a perfect
35 hexamer (T-11C), providing
further evidence that the effect of the spacer A/T region is specific
to C. trachomatis RNAP. These results suggest that a
35
hexamer, with the same sequence as the E. coli consensus
35 promoter element (TTGACA), and the spacer A/T region
can serve as important elements for recognition by C. trachomatis RNAP.
|
Transcription of the C. trachomatis rRNA P1 promoter
was affected by deletion of the
-CTD of E. coli
RNAP.
Our previous results demonstrated that the removal of
AT-rich sequences upstream of the putative
35 region significantly decreased transcription by both C. trachomatis and E. coli RNAP (22). Enhancement of transcription by an
AT-rich region upstream of an rRNA gene is suggestive of an UP element
(17). To test whether E. coli RNAP could
recognize this C. trachomatis sequence as an UP element, we
compared transcription by wild-type E. coli RNAP and mutant
E. coli RNAP that was unable to recognize the UP element
because of deletion of the
-CTD. With wild type E. coli
RNAP, transcription of a promoter template containing the proposed UP
element (
302 to +5 of C. trachomatis rRNA P1) was 11-fold
higher than transcription of a promoter template lacking the UP element
(
34 to +5) (Fig. 6, lanes 1 and 2). The
stimulation of transcription was lost when mutant E. coli
RNAP lacking the
-CTD was used (lanes 4 and 5). These results show
that C. trachomatis rRNA P1 contains an UP element that is
recognized by E. coli RNAP. Since the residues in
responsible for UP element recognition are conserved between E. coli and C. trachomatis (10, 11), these data
suggest that C. trachomatis RNAP also utilizes the rRNA P1
UP element.
|
| |
DISCUSSION |
|---|
|
|
|---|
We have identified four regions of C. trachomatis rRNA
P1 that contributed to the promoter activity of C. trachomatis RNAP: a
10 region, a
35 region, a novel spacer A/T
region just downstream of the
35 region, and an UP element. Three of
these regions are analogous to the corresponding regions in E. coli promoters, but the spacer A/T region was recognized only by
C. trachomatis RNAP.
Context effects limit the conclusions that can be made from the single
base substitutions. This is apparent in the analyses of the effect of
substitutions in the
35 region. Apparently, C. trachomatis
RNAP does not require a perfect
35 hexamer in the context of the
wild-type rRNA P1 promoter sequence. However, in the T-11C mutant (Fig.
5B), a
35 hexamer identical to the E. coli consensus
directs C. trachomatis RNAP to recognize a new promoter even
though there is an imperfect spacer A/T region. On the other hand,
creation of a good spacer A/T region is sufficient to allow for
transcription when the
35 sequence is imperfect (G-6A and G-6T [Fig.
5B]). It is tempting to speculate that the
35 region and the spacer
A/T region work cooperatively to anchor C. trachomatis RNAP
to the promoter.
The promoter sequences identified for C. trachomatis RNAP
resemble the E. coli
70 promoter structure.
This is consistent with the conservation of amino acid sequence between
A and
70 in subregions 2.4 and 4.2 (3, 12). Most substitutions in the
10 and
35 regions of
rRNA P1 that affected transcription by C. trachomatis RNAP
also affected transcription by E. coli RNAP, although there
were subtle differences in the recognition properties of the two
enzymes. For example, C. trachomatis RNAP did not recognize
the extended
10 motif in this promoter context. However, subregion
2.5 of
70, which is the region that recognizes this
motif, is well conserved between
A and
70
(1). The particular amino acid (E458) proposed to recognize the G residue of the TG motif is also conserved.
Our most striking result is the delineation of the spacer A/T region, which was important for transcription by C. trachomatis RNAP but not E. coli RNAP. Substitutions in this region demonstrated an AT sequence preference, and the spacing mutations showed that the location of the spacer A/T region was also important.
The role of the spacer A/T region may be explained in several ways. If
the spacer A/T region can function as an additional promoter element,
it may be required for specific contacts with C. trachomatis
RNAP. In fact, the spacer A/T region is immediately downstream of the
predicted location of the
35 promoter element, and the two regions
might form an extended
35 promoter element. Alternatively, the spacer
A/T region could serve as a binding site for a putative transcription
factor present in the C. trachomatis RNAP preparation. A
third possibility is that the preference for A or T residues in this
region may reflect the energetic contribution of these sequences to
promoter activity, such as with localized DNA strand melting. Finally,
the spacer A/T region is part of six consecutive A residues, which
could produce a nonstandard DNA structure that may affect promoter
recognition by C. trachomatis RNAP.
We propose that an AT-rich region from
52 to
34 functions as an UP
element to increase transcription from C. trachomatis rRNA
P1. We demonstrated a fourfold increase in transcription with C. trachomatis RNAP (reference 22 and data not
shown) and an 11-fold enhancement with E. coli RNAP
(reference 22 and Fig. 6). The effect of the UP
element on E. coli RNAP transcription was dependent on the
-CTD, strongly suggesting that the E. coli RNAP
subunit can recognize this heterologous UP element. We note that it is
not yet technically possible to confirm that the C. trachomatis RNAP
-CTD makes a contact with the UP element, as
this experiment will require the construction of mutant C. trachomatis RNAP lacking the
-CTD.
Interestingly, the UP element included a 12-bp sequence from
44 to
33 which was directly repeated from
29 to
18 (Fig. 5B). The
downstream repeat encompasses the spacer A/T region. As the
subunit
of RNAP recognizes the sequence of the UP element, it is intriguing to
speculate if the
subunit can also recognize the spacer A/T region.
Our results are consistent with the analysis of C. trachomatis MOMP P2 by Douglas and Hatch (2). They
reported that the first two positions of the putative
10 hexamer were
important for promoter activity, and in our analysis, the first two
positions of the potential
10 hexamer from
9 to
4 also showed the
greatest effect with substitution; 2-bp substitutions in the AT-rich
sequences upstream and downstream of the predicted MOMP P2
35
promoter element greatly abrogated promoter activity. We propose that
the AT-rich sequence upstream of the
35 promoter element of MOMP P2
is an UP element, which would explain the decreased promoter activity
with deletion of sequences upstream of
39 or with a 2-bp substitution
at
41 and
40. We also suggest that the AT-rich region downstream of
the
35 promoter element is the equivalent of a spacer A/T region.
Loss of promoter activity with a 2-bp substitution at
29 and
28
(equivalent to
26 and
25 of rRNA P1 [Fig.
7]) can be explained by alteration of
the spacer A/T region from AAAA to GAAA.
|
Analysis of other chlamydial promoters shows that many of them contain
potential
70
10 and
35 promoter sequences (Fig. 7).
A potential spacer A/T region can be identified immediately downstream
of the putative
35 element in many of these promoters. The potential
spacer A/T region is often part of a larger AT-rich sequence (6-8 bp).
A notable exception is the dnaK promoter, which lacks an
identifiable spacer A/T region but has a 5-of-6-bp match to the
E. coli consensus
35 hexamer and a perfect E. coli
10 hexamer (23). This
70-like
promoter structure may be sufficient for transcription by C. trachomatis RNAP. However, for other C. trachomatis
promoters, including rRNA P1, the spacer A/T region may compensate or
substitute for a suboptimal
35 element.
At this time, we cannot distinguish between the likely roles of the spacer A/T region as a promoter element that interacts differently with C. trachomatis and E. coli RNAPs or as a binding site for an activator of transcription that is present in the C. trachomatis RNAP preparation. Further characterization of the spacer A/T region will require purification of C. trachomatis RNAP to homogeneity.
| |
ACKNOWLEDGMENTS |
|---|
We thank members of the Engel lab and Carol Gross for support and suggestions.
This work was supported by grants from the NIH (AI 01247 to M.T., GM 37048 to R.L.G., and AI 24436 and AI 01348 to J.N.E.).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Box 0654, Division of Infectious Disease, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143-0654. Phone: (415) 476-7355. Fax: (415) 476-9364. E-mail: joanne_engel{at}quickmail.ucsf.edu.
Present address: Departments of Microbiology & Molecular Genetics
and Medicine, University of California, Irvine, Irvine, CA
92697-4025.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Barne, K. A.,
J. A. Bown,
S. J. W. Busby, and S. D. Minchin.
1997.
Region 2.5 of the Escherichia coli RNA polymerase 70 subunit is responsible for the recognition of the 'extended 10` motif at promoters.
EMBO J.
16:4034-4040[Medline].
|
| 2. |
Douglas, A. L., and T. P. Hatch.
1996.
Mutagenesis of the P2 promoter of the major outer membrane protein gene of Chlamydia trachomatis.
J. Bacteriol.
178:5573-5578 |
| 3. |
Engel, J., and D. Ganem.
1990.
A PCR-based approach to cloning sigma factors from eubacteria and its application to the isolation of a sigma70 homolog from Chlamydia trachomatis.
J. Bacteriol.
172:2447-2455 |
| 4. |
Engel, J.,
J. Pollack,
F. Malik, and D. Ganem.
1990.
Cloning and characterization of RNA polymerase core subunits of Chlamydia trachomatis using the polymerase chain reaction.
J. Bacteriol.
172:5732-5741 |
| 5. |
Engel, J. N., and D. Ganem.
1987.
Chlamydial rRNA operons: gene organization and identification of putative tandem promoters.
J. Bacteriol.
169:5678-5685 |
| 6. |
Everett, K. D. E., and T. P. Hatch.
1991.
Sequence analysis and lipid modification of the cysteine-rich envelope proteins of Chlamydia psittaci 6BC.
J. Bacteriol.
173:3821-3830 |
| 7. |
Fahr, M. J.,
A. L. Douglas,
W. Xia, and T. P. Hatch.
1995.
Characterization of late gene promoters of Chlamydia trachomatis.
J. Bacteriol.
177:4252-4260 |
| 8. | Fahr, M. J., K. S. Sriprakash, and T. P. Hatch. 1992. Convergent and overlapping transcripts of the Chlamydia trachomatis 7.5-kb plasmid. Plasmid 28:247-257[Medline]. |
| 9. |
Gaal, T.,
M. Bartlett,
W. Ross,
C. J. Turnbough, and R. Gourse.
1997.
Transcription regulation by initiating NTP concentration: rRNA synthesis in bacteria.
Science
278:2092-2097 |
| 10. |
Gaal, T.,
W. Ross,
E. Blatter,
H. Tang,
X. Jia,
V. Krishman,
N. Assa-munt,
R. Ebright, and R. Gourse.
1996.
DNA-binding determinants of the alpha subunit of RNA polymerase: novel DNA-binding domain architecture.
Genes Dev.
10:16-26 |
| 11. |
Gu, L.,
W. M. Wenman,
M. Remacha,
R. Meuser,
J. Coffin, and R. Kaul.
1995.
Chlamydia trachomatis RNA polymerase subunit: sequence and structural analysis.
J. Bacteriol.
177:2594-2601 |
| 12. |
Koehler, J. E.,
R. R. Burgess,
N. E. Thompson, and R. S. Stephens.
1990.
Chlamydia trachomatis RNA polymerase major subunit.
J. Biol. Chem.
265:13206-13214 |
| 13. | Lambden, P. R., J. S. Everson, M. E. Ward, and I. N. Clarke. 1990. Sulfur-rich proteins of Chlamydia trachomatis: developmentally regulated transcription of polycistronic mRNA from tandem promoters. Gene 87:105-112[Medline]. |
| 14. |
Lonetto, M.,
M. Gribskov, and C. A. Gross.
1992.
The 70 family: sequence conservation and evolutionary relationships.
J. Bacteriol.
174:3843-3849 |
| 15. |
Mathews, S. A., and K. S. Sriprakash.
1994.
The RNA polymerase of Chlamydia trachomatis has a flexible sequence requirement at the 10 and 35 boxes of its promoters.
J. Bacteriol.
176:3785-3789 |
| 16. |
Moulder, J.
1991.
Interaction of chlamydiae and host cells in vitro.
Microbiol. Rev.
55:143-190 |
| 17. |
Ross, W.,
K. K. Gosink,
J. Salomon,
K. Igarashi,
C. Zou,
A. Ishihama,
K. Severinov, and R. L. Gourse.
1993.
A third recognition element in bacterial promoters: DNA binding by the subunit of RNA polymerase.
Science
262:1407-1413 |
| 18. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. In Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 19. |
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467 |
| 20. | Schachter, J. 1988. The intracellular life of Chlamydia. Curr. Top. Microbiol. Immunol. 138:109-139[Medline]. |
| 21. | Stephens, R. S., S. Kalman, C. Fenner, and R. Davis. 1997. In Chlamydia Genome Project University of California at Berkeley and Stanford University. http;//chlamydia-www.berkeley.edu:4231. |
| 22. |
Tan, M., and J. N. Engel.
1996.
Identification of sequences necessary for transcription in vitro from the Chlamydia trachomatis rRNA P1 promoter.
J. Bacteriol.
178:6975-6982 |
| 23. |
Tan, M.,
B. Wong, and J. N. Engel.
1996.
Transcriptional organization and regulation of the dnaK and groE operons of Chlamydia trachomatis.
J. Bacteriol.
178:6983-6990 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |